These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6179861)

  • 1. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. III. Reactivity of certain anti-H-2.28 alloantisera with Qa-2 antigen.
    Iványi D; Cherry M; Démant P
    Immunogenetics; 1982; 15(5):477-84. PubMed ID: 6179861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. II. B10.D2(M504) (H-2dm1) mutant fails to express one of the two H-2.4-, 28 + Dd region molecules.
    Iványi D; Démant P
    Immunogenetics; 1982; 15(5):467-76. PubMed ID: 6980826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity of D-end products detected by anti-H-2.28 sera. I. A. molecule similar to Qa-2, detected in the BALB/cBy but not in the BALB/c-H-2dm2 mutant.
    Démant P; Roos MH
    Immunogenetics; 1982; 15(5):461-6. PubMed ID: 6179860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Qa-1 alloantigens. II. Evidence for the expression of two Qa-1 molecules by the Qa-1d genotype and for cross-reactivity between Qa-1 and H-2K.
    Cook RG; Jenkins RN; Flaherty L; Rich RR
    J Immunol; 1983 Mar; 130(3):1293-9. PubMed ID: 6822734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative aspects of anti-H-2Ld sera.
    Oudshoorn-Snoek M; Iványi D; Démant P
    Transplantation; 1981 Aug; 32(2):128-36. PubMed ID: 7292590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens.
    Stroynowski I; Forman J; Goodenow RS; Schiffer SG; McMillan M; Sharrow SO; Sachs DH; Hood L
    J Exp Med; 1985 May; 161(5):935-52. PubMed ID: 2580938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qa-1-associated antigens. IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition.
    Nell LJ; Cook RG; Rich RR
    Transplantation; 1982 Jul; 34(1):54-9. PubMed ID: 6181592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Qa2 subregion controls the expression of two antigens recognized by H-2-unrestricted cytotoxic T cells.
    Forman J; Trial J; Tonkonogy S; Flaherty L
    J Exp Med; 1982 Mar; 155(3):749-67. PubMed ID: 6174664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor.
    Armerding D; Sachs DH; Katz DH
    J Exp Med; 1974 Dec; 140(6):1717-22. PubMed ID: 4139236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Private specificity of H-2Ldx molecule detected serologically by a surface antigen redistribution method (capping).
    Ivány D; Démant P
    Tissue Antigens; 1982 Oct; 20(4):274-81. PubMed ID: 6183786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further molecular complexities of H-2 K- and D-region antigens.
    Démant P; Iványi D
    Nature; 1981 Mar; 290(5802):146-9. PubMed ID: 6163086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A third class I major histocompatibility complex antigen encoded by a gene in the D region of the H-2d haplotype recognized by cytotoxic T lymphocytes.
    Mann DW; Forman J
    Immunogenetics; 1988; 28(1):38-45. PubMed ID: 3259946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossreactivity between Qa-1 region and H-2K antigens.
    Figueroa F; Zaleska-Rutcznyska Z; Kusnierczyk P; Klein J
    Transplantation; 1983 Apr; 35(4):391-3. PubMed ID: 6836711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies.
    Sharrow SO; Flaherty L; Sachs DH
    J Exp Med; 1984 Jan; 159(1):21-40. PubMed ID: 6363595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-2L: demonstration of four new allelic products and independence of H-2D and H-2L molecules.
    Iványi D; Snoek M; Démant P
    Tissue Antigens; 1979 Sep; 14(3):233-50. PubMed ID: 93315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qa-like genes defined by CTL analysis of B10.W lines.
    Vucak I; Juretić A; Vidović D; Nagy ZA; Klein J
    J Immunol; 1984 May; 132(5):2232-6. PubMed ID: 6201536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to mouse major histocompatibility complex antigens.
    Ozato K; Mayer NM; Sachs DH
    Transplantation; 1982 Sep; 34(3):113-20. PubMed ID: 7135466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new determinant, Qa-m208, detected on T lymphocytes and transfected L cells by a Kb-specific monoclonal antibody.
    Oudshoorn-Snoek M; Mellor AL; Flavell RA; Démant P
    Immunogenetics; 1984; 19(6):461-74. PubMed ID: 6329949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.
    Shinohara N; Sachs DH
    J Exp Med; 1979 Sep; 150(3):432-44. PubMed ID: 113478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal analysis of the anti-Qa-1 cytotoxic T lymphocyte repertoire: definition of the Qa-1d and Qa-1c alloantigens and cross-reactivity with H-2.
    Aldrich CJ; Jenkins RN; Rich RR
    J Immunol; 1986 Jan; 136(2):383-8. PubMed ID: 2416805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.